The European regulator first launched its investigation into the potential suicidality risk associated with the medications in July 2023
SOUL trial demonstrated CV benefits of oral semaglutide with a 14% 3-P MACE reduction with all the three components contributing to the superior MACE reduction
While not approved to treat these conditions, in a clinical trial, people who dieted, exercised and took Zepbound for the treatment of obesity or overweight with weight-related medical problems observed changes in cholesterol and reductions in blood pressure and waist size
Controlled laboratory research involving Glutathione may include investigation into molecular mechanisms, compound stability, and experimental biochemical models
Mental health challenges such as depression and low motivation are common among clients with hypothyroidism
The plaintiffs were Cardone Ventures, LLC, and 10X Health Ventures, LLC, the latter of which was co-founded by Brecka and Workinger